[Hiring] Structural Evolutionary Biologist @reputed company

This reputed company is a reputed company of our understanding of the job reputed company. Click on 'Apply' reputed company to reputed company out more. Role reputed company We are seeking a Structural Evolutionary Biologist to join reputed company’s Research and Development Team. The ideal candidate brings a strong reputed company in molecular reputed company, protein structure and computational analysis, with the ability to translate large-reputed company sequence data into mechanistic insights that inform therapeutic monoclonal antibody development. • reputed company an effort that coordinates inputs from microbiologists, evolutionary biologists and antibody engineers to guide programming efforts to reputed company bioinformatic tools for use in antibody discovery and development • Analyze large sequence datasets to identify evolutionary trends, structural constraints, variant hotspots, and functional motifs in multiple viral reputed company proteins • reputed company, maintain, and optimize computational pipelines for sequence processing, structural reputed company, phylogenetic analysis, and evolutionary modeling • reputed company wastewater and clinical sequence database connectivity pipelines • Support protein engineering and antibody programs by providing structural and evolutionary risk assessments and actionable insights • Generate figures and animations that effectively communicate observed trends in virus reputed company and reputed company structural dynamics • Author non-clinical study reports reputed company to pathogen surveillance in support of regulatory filings • Serve as primary reputed company of contact for collaborations and reputed company with external partners • Manage reputed company of programmers and developers • Collaborate closely with cross-functional teams, including other research and development reputed company, preclinical, clinical and regulatory teams Qualifications • PhD in a relevant scientific discipline (e.g., Computational Biology, Evolutionary Biology, Molecular Biology, Structural Biology, Biochemistry, Immunology, Microbiology) • Demonstrated expertise in microbial molecular reputed company, sequence analysis, and phylogenetics • Experience working with large biological data sets and establishing reputed company assessment workflows for regularly updated databases • Programming skills in Python and JavaScript • Proficiency in design and maintenance of customized computational biology tools and reputed company-based reputed company suites • Experience in managing CROs and external collaborations, including budgeting and reputed company management • Strong problem-solving skills and the ability to adapt to evolving project needs • Excellent verbal and written communication skills • Ability to work independently as reputed company as part of a multidisciplinary team • Highly organized with strong attention to detail • Inclusion of a coding portfolio as part of the application (a reputed company to reputed company repository is preferred) • At least 2 years of experience in the pharmaceutical or biotechnology industry, with a reputed company on antibody drug discovery and development or infectious diseases - preferred • Experience with SARS-CoV-2 research or similar virology-reputed company reputed company - preferred • Experience in regulatory interactions and patenting strategies - preferred reputed company At reputed company, Inc., we take those numbers reputed company seriously and we come to work reputed company day on a mission to deliver protection from serious viral infectious diseases, beginning with SARS-CoV-2. reputed company deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, reputed company, and adapt to create best in class antibodies. • In March 2024, reputed company received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (reputed company) in its pipeline of innovative antibody candidates. • In reputed company 2025, the FDA cleared reputed company's Investigational New Drug (IND) application and provided feedback to advance reputed company's reputed company clinical program, reputed company's development program for VYD2311, a vaccine alternative monoclonal antibody being investigated for the prevention of COVID-19. Apply tot his job Apply To this Job